The National Institute for Health and Care Excellence (NICE) has given its nod to etrasimod (Velsipity, Pfizer) a once-daily pill treatment option for severe ulcerative colitis. The recommendation, ...

Even after Eli Lilly missed its first swing at the lucrative U.S. market with ulcerative colitis drug mirikizumab, the company’s launch is gaining steam overseas. Friday, England’s National Institute ...

AbbVie has received positive Final Draft Guidance from the National Institute for Health and Care Excellence (NICE) recommending Rinvoq (upadacitinib), within its marketing authorisation, as a ...

BASINGSTOKE, September 22, 2023 – Eli Lilly and Company announced today that the National Institute for Health and Care Excellence (NICE) have recommended mirikizumab for the treatment of adults with ...

Thousands of people could be set to benefit after NICE today (Monday, 11 March) recommended a new one-a-day pill as an option for treating severe ulcerative colitis. NICE’s final guidance on etrasimod ...

Ulcerative colitis patients who have had a colectomy continue to experience symptoms, and 46% say that if they could go back in time, they would want more information on the treatment choices, ...

The evaluation committee considered evidence submitted by AbbVie, a review of this submission by the external assessment group (EAG), and responses from stakeholders. See the committee papers for full ...

Patients with ulcerative colitis will be disappointed by news that cost regulators are planning to bar access to three treatments on the National Health Service in England. Patients with ulcerative ...

HODDESDON, England-- (BUSINESS WIRE)--The National Institute for Health and Care Excellence (NICE) has issued final guidance recommending the use of biologic therapies for the treatment of moderately ...

LONDON, Dec 17 (Reuters) - Britain's healthcare cost-effectiveness watchdog NICE said on Wednesday it had recommended the use of Remicade as an option for treating acute exacerbations of ulcerative ...